Zacks Investment Research Downgrades Voyager Therapeutics Inc (VYGR) to Sell

One research analyst has rated the stock with a sell rating ... including advanced Parkinson’s disease; a monogenic form of amyotrophic lateral sclerosis; Friedreich’s ataxia; Huntington’s disease, and spinal muscular atrophy.